Stay Curious. Stay Connected.
MailNewsletters♡Donate Now
Sign up
*Password must be at least 8 characters and contain one uppercase letter, one lowercase letter, one number and one symbol.
Already have an account?
By submitting, you consent that you are at least 18 years of age and to receive information about MPR's or APMG entities' programs and offerings. The personally identifying information you provide will not be sold, shared, or used for purposes other than to communicate with you about MPR, APMG entities, and its sponsors. You may opt-out at any time clicking the unsubscribe link at the bottom of any email communication. View our Privacy Policy.
Sign in to your profile
Forgot Password?
New to MPR News?
Welcome back
to news
for you
Reset Password

Enter the username on file and we'll send you a code to reset your password.

Still require assistance or not sure what your User Name is?
Welcome back
to news
for you
Email Verification

A verification code has been emailed to

Still awaiting the code?
Big Books & Bold Ideas with Kerri Miller
Kerri Miller and Kelly Gordon

‘Chasing My Cure: A Doctor's Race to Turn Hope into Action’

David Fajgenbaum, author of "Chasing My Cure."
David Fajgenbaum, author of "Chasing My Cure."
Photo by Rebecca McAlpin | Book cover courtesy of Random House

Go Deeper.

Create an account or log in to save stories.

Log inCreate a free Account

Like this?

Thanks for liking this story! We have added it to a list of your favorite stories.

Show me!

David Fajgenbaum was in medical school when the symptoms of a mysterious disease started to ravage his body. “I felt doomed,” he writes in his new book. “I knew I was dying. I just knew.”

He endured years of hospitalizations and experimental treatments — even coming close to death five times — before his own training and perseverance led him to a drug that saved his life, even though it wasn't FDA-approved as a treatment for his disease.

Tuesday on MPR News, Fajgenbaum talked with Kerri Miller about his memoir, "Chasing My Cure" — and his hope that his journey will highlight the need to leverage already approved drugs for a variety of illnesses.